8 completed, 1 terminated, 1 withdrawn. 3 Phase 1, 3 Phase 2, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
| Not applicable | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Granuloma Annulare: new trials by email Literature Review of Granuloma Annulare trials Research Report on Granuloma Annulare
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tyrosine Kinase 2 (TYK2) for GA and CS Deucravacitinib - Sarcoidosis, Granuloma Annulare | Phase 2 | Withdrawn | Yale University | 2025-03-01 | 2025-04-29 | |
| Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care AI-based medical device for aided diagnosis in Dermatology - Dermatitis, Melanoma (Skin Cancer) | Completed | AI Labs Group S.L | 16 | 2024-06-01 | 2026-02-24 | |
| Janus Kinase Inhibition in Granuloma Annulare Abrocitinib 200 mg - Granuloma Annulare | Phase 2 | Completed | William Damsky | 10 | 2023-10-27 | 2026-10-07 |
| Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare AC-1101 - Granuloma Annulare | Phase 1 | Completed | TWi Biotechnology, Inc. | 13 | 2022-10-03 | 2024-10-15 |
| Evaluation of 41 Cases of Pediatric Granuloma Annulare Granuloma Annulare | Completed | Istanbul Training and Research Hospital | 41 | 2022-03-11 | 2022-07-25 | |
| Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare Tofacitinib 5 mg twice daily - Cutaneous Sarcoidosis, Granuloma Annulare | Phase 1 | Completed | Yale University | 15 | 2019-04-11 | 2021-07-14 |
| Pain Outcomes Following Intralesional Corticosteroid Injections Corticosteroid with lidocaine, Corticosteroid with normal saline - Keloid, Alopecia Areata | Phase 4 | Completed | Vanderbilt University Medical Center | 31 | 2018-10-01 | 2021-03-11 |
| Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy Granuloma Annulare | Completed | Henry Ford Health System | 6 | 2008-05-01 | 2024-04-30 | |
| Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix UVB Irradiation - Keloid, Scleroderma, Localized | Phase 1 / Phase 2 | Completed | University of Michigan | 33 | 2002-08-01 | 2015-05-01 |
| UVA1 Light for Scleroderma and Similar Conditions German manufactured UVA1 emitting light system - Keloid, Scleroderma | Not applicable | Terminated | University of Michigan | 23 | 1997-01-01 | 2015-07-27 |
Keloid (3) · Scleroderma, Localized (3) · Acne Keloid (2) · Acne Vulgaris (2) · Cicatrix (2) · Scleroderma, Diffuse (2) · Alopecia (1) · Alopecia Areata (1) · Cicatrix, Hypertrophic (1) · Dermatitis (1) · Dermoid Cyst (1) · Herpes Simplex (1) · Inhibition, Psychological (1) · Keratoacanthoma (1)
Collagen Diseases (10) · Connective Tissue Diseases (10) · Granuloma (10) · Necrobiotic Disorders (10) · Pathologic Processes (10) · Pathological Conditions, Signs and Symptoms (10) · Skin and Connective Tissue Diseases (10) · Skin Diseases (9) · Acneiform Eruptions (4) · Hair Diseases (4) · Fibrosis (3) · Folliculitis (2) · Hypersensitivity (2) · Hypotrichosis (2) · Immune System Diseases (2)
Adrenal Cortex Hormones (1) · Lidocaine (1) · Saline Solution (1) · abrocitinib (1) · deucravacitinib (1) · tofacitinib (1)
University of Michigan (2) · Yale University (2) · AI Labs Group S.L (1) · Henry Ford Health System (1) · Istanbul Training and Research Hospital (1) · TWi Biotechnology, Inc. (1) · Vanderbilt University Medical Center (1) · William Damsky (1)
United States (8) · Spain (1) · Turkey (Türkiye) (1)
Antonio Martorell, PhD (1) · Brian Drolet, MD (1) · Iltefat H Hamzavi, MD (1) · John J Voorhees, MD (1) · William Damsky, M.D. (1) · William Damsky, M.D., Ph.D. (1) · William Damsky, MD (1) · William Damsky, MD, PhD (1) · Yolanda Helfrich, MD (1)